These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21885852)

  • 1. Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study.
    Liu J; Fox CS; Hickson D; Bidulescu A; Carr JJ; Taylor HA
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2715-22. PubMed ID: 21885852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary patterns, abdominal visceral adipose tissue, and cardiometabolic risk factors in African Americans: the Jackson heart study.
    Liu J; Hickson DA; Musani SK; Talegawkar SA; Carithers TC; Tucker KL; Fox CS; Taylor HA
    Obesity (Silver Spring); 2013 Mar; 21(3):644-51. PubMed ID: 23592674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study.
    Liu J; Musani SK; Bidulescu A; Carr JJ; Wilson JG; Taylor HA; Fox CS
    Atherosclerosis; 2012 Oct; 224(2):521-5. PubMed ID: 22902209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential associations of abdominal visceral, subcutaneous adipose tissue with cardiometabolic risk factors between African and European Americans.
    Liu J; Coady S; Carr JJ; Hoffmann U; Taylor HA; Fox CS
    Obesity (Silver Spring); 2014 Mar; 22(3):811-8. PubMed ID: 23408700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors.
    Yi W; Kim K; Im M; Ryang S; Kim EH; Kim M; Jeon YK; Kim SS; Kim BH; Pak K; Kim IJ; Kim SJ
    Sci Rep; 2022 Jan; 12(1):387. PubMed ID: 35013484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.
    Liu J; Fox CS; Hickson DA; May WD; Hairston KG; Carr JJ; Taylor HA
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5419-26. PubMed ID: 20843952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
    Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study.
    Bidulescu A; Liu J; Hickson DA; Hairston KG; Fox ER; Arnett DK; Sumner AE; Taylor HA; Gibbons GH
    BMC Cardiovasc Disord; 2013 Feb; 13():9. PubMed ID: 23433085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study.
    Therkelsen KE; Pedley A; Speliotes EK; Massaro JM; Murabito J; Hoffmann U; Fox CS
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):863-70. PubMed ID: 23349188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity.
    Nazare JA; Smith JD; Borel AL; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
    Am J Clin Nutr; 2012 Oct; 96(4):714-26. PubMed ID: 22932278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study.
    North KE; Graff M; Franceschini N; Reiner AP; Feitosa MF; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):9-16. PubMed ID: 21900826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults.
    Katzmarzyk PT; Heymsfield SB; Bouchard C
    Am J Clin Nutr; 2013 Mar; 97(3):480-6. PubMed ID: 23364010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal visceral and subcutaneous adipose tissues in association with cardiometabolic risk in children and adolescents: the China Child and Adolescent Cardiovascular Health (CCACH) study.
    Yan Y; Liu J; Zhao X; Cheng H; Huang G; Mi J;
    BMJ Open Diabetes Res Care; 2019; 7(1):e000824. PubMed ID: 31875134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study.
    Liu J; Fox CS; Hickson D; Sarpong D; Ekunwe L; May WD; Hundley GW; Carr JJ; Taylor HA
    Diabetes Care; 2010 Jul; 33(7):1635-9. PubMed ID: 20413524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels.
    Demerath EW; Reed D; Rogers N; Sun SS; Lee M; Choh AC; Couch W; Czerwinski SA; Chumlea WC; Siervogel RM; Towne B
    Am J Clin Nutr; 2008 Nov; 88(5):1263-71. PubMed ID: 18996861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.
    Fox CS; Massaro JM; Hoffmann U; Pou KM; Maurovich-Horvat P; Liu CY; Vasan RS; Murabito JM; Meigs JB; Cupples LA; D'Agostino RB; O'Donnell CJ
    Circulation; 2007 Jul; 116(1):39-48. PubMed ID: 17576866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk.
    Kaess BM; Pedley A; Massaro JM; Murabito J; Hoffmann U; Fox CS
    Diabetologia; 2012 Oct; 55(10):2622-2630. PubMed ID: 22898763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal cut-points of visceral adipose tissue areas for cardiometabolic risk factors in a Chinese population: a cross-sectional study.
    Huo L; Li K; Deng W; Wang L; Xu L; Shaw JE; Jia P; Zhou D; Cheng XG
    Diabet Med; 2019 Oct; 36(10):1268-1275. PubMed ID: 31257674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral and subcutaneous fat quality and cardiometabolic risk.
    Rosenquist KJ; Pedley A; Massaro JM; Therkelsen KE; Murabito JM; Hoffmann U; Fox CS
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):762-71. PubMed ID: 23664720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women.
    Wildman RP; Janssen I; Khan UI; Thurston R; Barinas-Mitchell E; El Khoudary SR; Everson-Rose SA; Kazlauskaite R; Matthews KA; Sutton-Tyrrell K
    Am J Clin Nutr; 2011 Apr; 93(4):719-26. PubMed ID: 21346089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.